Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04542395

COVID-2019 Testing and Vaccination Among African American and Latinx Public Housing Residents

Multilevel Participatory Intervention to Reduce Barriers and Promote Social and Behavioral Facilitators of COVID-19 Testing Among African Americans and Latinx Public Housing Residents

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Charles Drew University of Medicine and Science · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This proposal seeks to enhance acceptability and uptake of COVID-19 testing and vaccination to engage African American and Latinx public housing residents in South Los Angeles. Given the multiple disparities experienced by public housing residents, the investigators will utilize a theoretically-based, multidisciplinary and culturally tailored intervention to reduce barriers and implement innovate strategies to engage this population in the uptake of COVID-19 testing and vaccination.

Detailed description

Through the engagement and empowerment of 15 trained COVID-19 health ambassadors, the investigators will jointly implement and evaluate a theoretically based and culturally-sensitive socio-behavioral intervention that will: a) reduce mistrust, fatalistic beliefs, and related psychosocial barriers that hinder COVID-19 testing and vaccination; b) increase receptivity and willingness for uptake of COVID-19 testing and vaccination; and c) assess perceived impact of psychosocial and health outcomes related to COVID-19 testing and vaccination for 310 African American and Latinx public housing residents.

Conditions

Interventions

TypeNameDescription
BEHAVIORALIncreasing Willingness and Uptake of COVID-19 Testing and VaccinationProvide/enhance knowledge, modify attitudes, motivate and provide skills and resources to reduce COVID-19 related risk and challenges and increase willingness and uptake in COVID-19 testing and vaccination.

Timeline

Start date
2023-06-01
Primary completion
2025-11-30
Completion
2025-11-30
First posted
2020-09-09
Last updated
2022-08-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04542395. Inclusion in this directory is not an endorsement.